Pharma News – 23.01.2023 to 29.01.2023
Mankind Pharma invests in Actimed Therapeutics to support the latter’s development of treatment for cancer cachexia. On 23 January 2023, …
Mankind Pharma invests in Actimed Therapeutics to support the latter’s development of treatment for cancer cachexia. On 23 January 2023, …
On 4 February 2023, Lupin announced the recall of Clobetasol propionate cream over quality issues. As per the USFDA [1], the pharma …
Lupin issues nationwide recall of Clobetasol propionate cream. Read More »
The USFDA[1] has revealed that Global Pharma Healthcare recalls all the batches of artificial tears lubricant eye drops from the …
Global Pharma Healthcare recalls Artificial Tears Lubricant eye drops. Read More »
USFDA issues OAI notice for Torrent Pharma’s Indrad facility in Gujarat.In response to this notice, Torrent Pharma has clarified that …
On 23 January 2023, Mankind Pharma announced its move to invest in the UK-based clinical-stage specialty pharma company Actimed Therapeutics. …
Cancer Cachexia: Mankind Pharma’s association with Actimed Therapeutics Read More »
Aculys Pharma and Four H have announced a research collaboration to explore the potential of wearable devices to improve clinical …
Zydus receives USFDA’a approval for marketing its epilepsy and menopause drugs. Pharma news- On 2 December 2022, Zydus received the …
The global pharmaceutical industry is experiencing a massive revamp by adopting several latest technologies, including big data. It is pretty …
Is Big Data Analytics revamping the Pharmaceutical Industry? Read More »
GC Pharma and Tottori University have collaborated to accelerate the global development of the chaperone therapy of GM1 gangliosidosis (GM1). …
Moderna collaborates with Thermo Fischer Scientific to ramp up its COVID – 19 vaccine production Moderna Inc had entered into …
Moderna collaborates with Thermo Fischer Scientific Read More »